Characteristics and function of cardiac mitochondrial nitric oxide synthase

Journal of Physiology

Volumn 587, Issue 4, 2009, Pages 851-872

  Dedkova, Elena N ^a   Blatter, Lothar A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDINE DERIVATIVE; ANTIMYCIN A1; ARGINASE; ARGININE; CALCIUM ION; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCENT DYE; INDUCIBLE NITRIC OXIDE SYNTHASE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N5 (1 IMINOETHYL)ORNITHINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OLIGOMYCIN; REACTIVE OXYGEN METABOLITE; ROTENONE; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; MITOCHONDRIAL NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE; LASER MICROSCOPY; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY CHAIN; ADULT; CAT; CELL MEMBRANE PERMEABILITY; CONFOCAL LASER MICROSCOPY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; FEMALE; MALE; MITOCHONDRION; PERMEABILITY TRANSITION PORE;

ANIMALS; CATS; FEMALE; MALE; MITOCHONDRIA, HEART; MYOCARDIUM; MYOCYTES, CARDIAC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN SPECIES;

EID: 60349109393     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.165423     Document Type: Article

References (143)

1. Adak S, Aulak KS & Stuehr DJ (2002 a). Direct evidence for nitric oxide production by a nitric-oxide synthase-like protein from Bacillus subtilis. J Biol Chem 277, 16167-16171.
2. Adak S, Bilwes AM, Panda K, Hosfield D, Aulak KS, McDonald JF, Tainer JA, Getzoff ED, Crane BR & Stuehr DJ (2002 b). Cloning, expression, and characterization of a nitric oxide synthase protein from Deinococcus radiodurans. Proc Natl Acad Sci U S A 99, 107-112.
3. Adak S, Wang Q & Stuehr DJ (2000). Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism. J Biol Chem 275, 33554-33561.
4. Bassani JW, Bassani RA & Bers DM (1993). Twitch-dependent SR Ca accumulation and release in rabbit ventricular myocytes. Am J Physiol Cell Physiol 265, C533-C540.
5. Bates TE, Loesch A, Burnstock G & Clark JB (1996). Mitochondrial nitric oxide synthase: A ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 218, 40-44.
6. Belge C, Massion PB, Pelat M & Balligand JL (2005). Nitric oxide and the heart: Update on new paradigms. Ann N Y Acad Sci 1047, 173-182.
7. Berka V, Wang LH & Tsai AL (2008). Oxygen-induced radical intermediates in the nNOS oxygenase domain regulated by L-arginine, tetrahydrobiopterin, and thiol. Biochemistry 47, 405-420.
8. Berka V, Wu G, Yeh HC, Palmer G & Tsai AL (2004). Three different oxygen-induced radical species in endothelial nitric-oxide synthase oxygenase domain under regulation by L-arginine and tetrahydrobiopterin. J Biol Chem 279, 32243-32251.
9. Bevers LM, Braam B, Post JA, van Zonneveld AJ, Rabelink TJ, Koomans HA, Verhaar MC & Joles JA (2006). Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension 47, 87-94.
10. Boveris A, D'Amico G, Lores-Arnaiz S & Costa LE (2003). Enalapril increases mitochondrial nitric oxide synthase activity in heart and liver. Antioxid Redox Signal 5, 691-697.
11. 2+ release. Free Radic Biol Med 29, 343-348.
12. Brodsky SV, Gao S, Li H & Goligorsky MS (2002). Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol 283, H2130-H2139.
13. Brookes PS (2004). Mitochondrial nitric oxide synthase. Mitochondrion 3, 187-204.
14. Brookes PS, Salinas EP, Darley-Usmar K, Eiserich JP, Freeman BA, Darley-Usmar VM & Anderson PG (2000). Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 275, 20474-20479.
15. Brown GC & Borutaite V (2007). Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 75, 283-290.
16. Calaghan S, Kozera L & White E (2008). Compartmentalisation of cAMP-dependent signalling by caveolae in the adult cardiac myocyte. J Mol Cell Cardiol 45, 88-92.
17. Closs EI, Scheld JS, Sharafi M & Forstermann U (2000). Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol 57, 68-74.
18. Costa LE, La-Padula P, Lores-Arnaiz S, D'Amico G, Boveris A, Kurnjek ML & Basso N (2002). Long-term angiotensin II inhibition increases mitochondrial nitric oxide synthase and not antioxidant enzyme activities in rat heart. J Hypertens 20, 2487-2494.
19. Csordas A, Pankotai E, Snipes JA, Cselenyak A, Sarszegi Z, Cziraki A, Gaszner B, Papp L, Benko R, Kiss L, Kovacs E, Kollai M, Szabo C, Busija DW & Lacza Z (2007). Human heart mitochondria do not produce physiologically relevant quantities of nitric oxide. Life Sci 80, 633-637.
20. Davidson SM & Duchen MR (2006). Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance. Cardiovasc Res 71, 10-21.
21. 2+ uptake in bovine vascular endothelial cells. J Physiol 539, 77-91.
22. + by nitric oxide in cultured bovine vascular endothelial cells. Am J Physiol Cell Physiol 289, C836-C845.
23. Dedkova EN & Blatter LA (2006). Mitochondrial calcium uptake stimulates nitric oxide and ROS production by mitochondria-specific nitric oxide synthase (mtNOS) in cat ventricular myocytes. Biophys J 90, 521a.
24. 2+ and the heart. Cell Calcium 44, 77-91.
25. Dedkova EN, Ji X, Lipsius SL & Blatter LA (2004). Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am J Physiol Cell Physiol 286, C406-C415.
26. Dedkova EN, Ji X, Wang YG, Blatter LA & Lipsius SL (2003). Signaling mechanisms that mediate nitric oxide production induced by acetylcholine exposure and withdrawal in cat atrial myocytes. Circ Res 93, 1233-1240.
27. 2+ current in cat atrial myocytes. J Physiol 542, 711-723.
28. Dedkova EN, Wang YG, Ji X, Blatter LA, Samarel AM & Lipsius SL (2007). Signalling mechanisms in contraction-mediated stimulation of intracellular NO production in cat ventricular myocytes. J Physiol 580, 327-345.
29. Delp MD, Behnke BJ, Spier SA, Wu G & Muller-Delp JM (2008). Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles. J Physiol 586, 1161-1168.
30. Desrois M, Sciaky M, Lan C, Cozzone PJ & Bernard M (2000). L-Arginine during long-term ischemia: Effects on cardiac function, energetic metabolism and endothelial damage. J Heart Lung Transplant 19, 367-376.
31. Desrois M, Sciaky M, Lan C, Cozzone PJ & Bernard M (2003). Preservation of amino acids during long term ischemia and subsequent reflow with supplementation of L-arginine, the nitric oxide precursor, in the rat heart. Amino Acids 24, 141-148.
32. Doutreleau S, Mettauer B, Piquard F, Rouyer O, Schaefer A, Lonsdorfer J & Geny B (2006). Chronic L-arginine supplementation enhances endurance exercise tolerance in heart failure patients. Int J Sports Med 27, 567-572.
33. Elfering SL, Sarkela TM & Giulivi C (2002). Biochemistry of mitochondrial nitric-oxide synthase. J Biol Chem 277, 38079-38086.
34. Feron O & Balligand JL (2006). Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 69, 788-797.
35. French S, Giulivi C & Balaban RS (2001). Nitric oxide synthase in porcine heart mitochondria: Evidence for low physiological activity. Am J Physiol Heart Circ Physiol 280, H2863-H2867.
36. Gao YT, Panda SP, Roman LJ, Martasek P, Ishimura Y & Masters BS (2007 a). Oxygen metabolism by neuronal nitric-oxide synthase. J Biol Chem 282, 7921-7929.
37. Gao YT, Roman LJ, Martasek P, Panda SP, Ishimura Y & Masters BS (2007 b). Oxygen metabolism by endothelial nitric-oxide synthase. J Biol Chem 282, 28557-28565.
38. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ & Knowles RG (1997). 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272, 4959-4963.
39. Ghafourifar P, Schenk U, Klein SD & Richter C (1999). Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J Biol Chem 274, 31185-31188.
40. Giulivi C, Poderoso JJ & Boveris A (1998). Production of nitric oxide by mitochondria. J Biol Chem 273, 11038-11043.
41. Gonzales GF, Chung FA, Miranda S, Valdez LB, Zaobornyj T, Bustamante J & Boveris A (2005). Heart mitochondrial nitric oxide synthase is upregulated in male rats exposed to high altitude (4,340 m). Am J Physiol Heart Circ Physiol 288, H2568-H2573.
42. Griffith OW & Stuehr DJ (1995). Nitric oxide synthases: Properties and catalytic mechanism. Annu Rev Physiol 57, 707-736.
43. Guo FQ & Crawford NM (2005). Arabidopsis nitric oxide synthase1 is targeted to mitochondria and protects against oxidative damage and dark-induced senescence. Plant Cell 17, 3436-3450.
44. Gupta KJ, Stoimenova M & Kaiser WM (2005). In higher plants, only root mitochondria, but not leaf mitochondria reduce nitrite to NO, in vitro and in situ. J Exp Bot 56, 2601-2609.
45. Hah JM, Roman LJ, Martasek P & Silverman RB (2001). Reduced amide bond peptidomimetics (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N′-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. J Med Chem 44, 2667-2670.
46. Hecker M, Sessa WC, Harris HJ, Anggard EE & Vane JR (1990). The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci U S A 87, 8612-8616.
47. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281, 627-630.
48. Horikawa YT, Patel HH, Tsutsumi YM, Jennings MM, Kidd MW, Hagiwara Y, Ishikawa Y, Insel PA & Roth DM (2008). Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J Mol Cell Cardiol 44, 123-130.
49. Hotta Y, Otsuka-Murakami H, Fujita M, Nakagawa J, Yajima M, Liu W, Ishikawa N, Kawai N, Masumizu T & Kohno M (1999). Protective role of nitric oxide synthase against ischemia-reperfusion injury in guinea pig myocardial mitochondria. Eur J Pharmacol 380, 37-48.
50. 2+ uptake and thapsigargin sensitivity in permeabilized rabbit and rat ventricular myocytes. Circ Res 73, 820-828.
51. Huser J, Rechenmacher CE & Blatter LA (1998). Imaging the permeability pore transition in single mitochondria. Biophys J 74, 2129-2137.
52. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, Utsumi H, Machida Y, Egashira K & Takeshita A (2000). Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86, 152-157.
53. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K, Arimura K, Egashira K & Takeshita A (1999). Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85, 357-363.
54. Jung AS, Kubo H, Wilson R, Houser SR & Margulies KB (2006). Modulation of contractility by myocyte-derived arginase in normal and hypertrophied feline myocardium. Am J Physiol Heart Circ Physiol 290, H1756-H1762.
55. Kalivendi S, Hatakeyama K, Whitsett J, Konorev E, Kalyanaraman B & Vasquez-Vivar J (2005). Changes in tetrahydrobiopterin levels in endothelial cells and adult cardiomyocytes induced by LPS and hydrogen peroxide - a role for GFRP? Free Radic Biol Med 38, 481-491.
56. Kanai A, Epperly M, Pearce L, Birder L, Zeidel M, Meyers S, Greenberger J, de Groat W, Apodaca G & Peterson J (2004). Differing roles of mitochondrial nitric oxide synthase in cardiomyocytes and urothelial cells. Am J Physiol Heart Circ Physiol 286, H13-H21.
57. Kanai AJ, Mesaros S, Finkel MS, Oddis CV, Birder LA & Malinski T (1997). β-Adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am J Physiol Cell Physiol 273, C1371-C1377.
58. Kanai AJ, Pearce LL, Clemens PR, Birder LA, VanBibber MM, Choi SY, de Groat WC & Peterson J (2001). Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A 98, 14126-14131.
59. Kato K & Giulivi C (2006). Critical overview of mitochondrial nitric-oxide synthase. Front Biosci 11, 2725-2738.
60. Kawahara K, Hachiro T, Yokokawa T, Nakajima T, Yamauchi Y & Nakayama Y (2006). Ischemia/reperfusion-induced death of cardiac myocytes: possible involvement of nitric oxide in the coordination of ATP supply and demand during ischemia. J Mol Cell Cardiol 40, 35-46.
61. Kaye DM, Parnell MM & Ahlers BA (2002). Reduced myocardial and systemic L-arginine uptake in heart failure. Circ Res 91, 1198-1203.
62. Kaye DM, Wiviott SD, Balligand JL, Simmons WW, Smith TW & Kelly RA (1996). Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res 78, 217-224.
63. Kelly RA, Balligand JL & Smith TW (1996). Nitric oxide and cardiac function. Circ Res 79, 363-380.
64. Klatt P, Schmidt K, Lehner D, Glatter O, Bachinger HP & Mayer B (1995). Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J 14, 3687-3695.
65. Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, Scherez J, Blum M, Laniado S, Iaina A et al. (1995). Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol 26, 1251-1256.
66. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y & Nagano T (1998). Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Anal Chem 70, 2446-2453.
67. La Padula P, Bustamante J, Czerniczyniec A & Costa LE (2008). Time course of regression of the protection conferred by simulated high altitude to rat myocardium: Correlation with mtNOS. J Appl Physiol 105, 951-957.
68. Lacza Z, Kozlov AV, Pankotai E, Csordas A, Wolf G, Redl H, Kollai M, Szabo C, Busija DW & Horn TF (2006 a). Mitochondria produce reactive nitrogen species via an arginine-independent pathway. Free Radic Res 40, 369-378.
69. Lacza Z, Pankotai E, Csordas A, Gero D, Kiss L, Horvath EM, Kollai M, Busija DW & Szabo C (2006 b). Mitochondrial NO and reactive nitrogen species production: Does mtNOS exist? Nitric Oxide 14, 162-168.
70. Lacza Z, Snipes JA, Zhang J, Horvath EM, Figueroa JP, Szabo C & Busija DW (2003). Mitochondrial nitric oxide synthase is not eNOS, nNOS or iNOS. Free Radic Biol Med 35, 1217-1228.
71. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE & Harrison DG (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111, 1201-1209.
72. Levrand S, Vannay-Bouchiche C, Pesse B, Pacher P, Feihl F, Waeber B & Liaudet L (2006). Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med 41, 886-895.
73. Lohn M, Furstenau M, Sagach V, Elger M, Schulze W, Luft FC, Haller H & Gollasch M (2000). Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res 87, 1034-1039.
74. 2+ and hypoxia. Studies in rat heart mitochondria. Amino Acids 22, 381-389.
75. Marsh D (1996). Peptide models for membrane channels. Biochem J 315, 345-361.
76. Massion PB & Balligand JL (2003). Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol 546, 63-75.
77. Massion PB, Feron O, Dessy C & Balligand JL (2003). Nitric oxide and cardiac function: Ten years after, and continuing. Circ Res 93, 388-398.
78. Maxwell AJ, Zapien MP, Pearce GL, MacCallum G & Stone PH (2002). Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol 39, 37-45.
79. Mendes Ribeiro AC, Brunini TM, Ellory JC & Mann GE (2001). Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure. Cardiovasc Res 49, 697-712.
80. Moens AL, Takimoto E, Tocchetti CG, Chakir K, Bedja D, Cormaci G, Ketner EA, Majmudar M, Gabrielson K, Halushka MK, Mitchell JB, Biswal S, Channon KM, Wolin MS, Alp NJ, Paolocci N, Champion HC & Kass DA (2008). Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: Efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117, 2626-2636.
81. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K & Munzel T (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90, E58-E65.
82. Moncada S, Palmer RM & Higgs EA (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-142.
83. 6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J Med Chem 37, 3886-3888.
84. Moradi H, Kwok V & Vaziri ND (2006). Effect of chronic renal failure on arginase and argininosuccinate synthetase expression. Am J Nephrol 26, 310-318.
85. Nazarewicz RR, Zenebe WJ, Parihar A, Parihar MS, Vaccaro M, Rink C, Sen CK & Ghafourifar P (2007). 12(S)-Hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. Arch Biochem Biophys 468, 114-120.
86. Obrosova IG (2006). Peroxynitrite and cardiomyocyte cell death: An evolving story. A commentary on 'Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo '. Free Radic Biol Med 41, 866-868.
87. Packer MA & Murphy MP (1994). Peroxynitrite causes calcium efflux from mitochondria which is prevented by Cyclosporin A. FEBS Lett 345, 237-240.
88. Parihar MS, Nazarewicz RR, Kincaid E, Bringold U & Ghafourifar P (2008 c). Association of mitochondrial nitric oxide synthase activity with respiratory chain complex I. Biochem Biophys Res Commun 366, 23-28.
89. Parihar A, Parihar MS, Chen Z & Ghafourifar P (2008 a). mAtNOS1 induces apoptosis of human mammary adenocarcinoma cells. Life Sci 82, 1077-1082.
90. Parihar MS, Parihar A, Chen Z, Nazarewicz R & Ghafourifar P (2008 d). mAtNOS1 regulates mitochondrial functions and apoptosis of human neuroblastoma cells. Biochim Biophys Acta 1780, 921-926.
91. Parihar MS, Parihar A, Villamena FA, Vaccaro PS & Ghafourifar P (2008 e). Inactivation of mitochondrial respiratory chain complex I leads mitochondrial nitric oxide synthase to become pro-oxidative. Biochem Biophys Res Commun 367, 761-767.
92. Parihar A, Vaccaro P & Ghafourifar P (2008 b). Nitric oxide irreversibly inhibits cytochrome oxidase at low oxygen concentrations: evidence for inverse oxygen concentration-dependent peroxynitrite formation. IUBMB Life 60, 64-67.
93. Patterson SD, Spahr CS, Daugas E, Susin SA, Irinopoulou T, Koehler C & Kroemer G (2000). Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ 7, 137-144.
94. Peluffo RD (2007). L-Arginine currents in rat cardiac ventricular myocytes. J Physiol 580, 925-936.
95. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P & Di Lisa F (1999). Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76, 725-734.
96. Poot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, Hanzel DK, Lugade AG, Singer VL & Haugland RP (1996). Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. J Histochem Cytochem 44, 1363-1372.
97. Post H & Pieske B (2006). Arginase: A modulator of myocardial function. Am J Physiol Heart Circ Physiol 290, H1747-H1748.
98. Pou S, Pou WS, Bredt DS, Snyder SH & Rosen GM (1992). Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267, 24173-24176.
99. Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K & Kubo SH (1996). Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 93, 2135-2141.
100. Remillard CV & Yuan JX (2007). Cardiac L-arginine transport: The CAT is back. J Physiol 580, 699-700.
101. Reyes AA, Karl IE & Klahr S (1994). Role of arginine in health and in renal disease. Am J Physiol Renal Physiol 267, F331-F346.
102. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B & Sandvig K (1999). Extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 10, 961-974.
103. Rosen GM, Tsai P, Weaver J, Porasuphatana S, Roman LJ, Starkov AA, Fiskum G & Pou S (2002). The role of tetrahydrobiopterin in the regulation of neuronal nitricoxide synthase-generated superoxide. J Biol Chem 277, 40275-40280.
104. Roychowdhury S, Luthe A, Keilhoff G, Wolf G & Horn TF (2002). Oxidative stress in glial cultures: Detection by DAF-2 fluorescence used as a tool to measure peroxynitrite rather than nitric oxide. Glia 38, 103-114.
105. Rubenstein DS & Lipsius SL (1995). Premature beats elicit a phase reversal of mechanoelectrical alternans in cat ventricular myocytes. A possible mechanism for reentrant arrhythmias. Circulation 91, 201-214.
106. Saavedra-Molina A, Ramirez-Emiliano J, Clemente-Guerrero M, Perez-Vazquez V, Aguilera-Aguirre L & Gonzalez-Hernandez JC (2003). Mitochondrial nitric oxide inhibits ATP synthesis. Effect of free calcium in rat heart. Amino Acids 24, 95-102.
107. Schulz E, Jansen T, Wenzel P, Daiber A & Munzel T (2008). Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10, 1115-1126.
108. 2+ signals by mitochondria in cat ventricular myocytes. Am J Physiol Cell Physiol 291, C840-C850.
109. Sessa WC, Hecker M, Mitchell JA & Vane JR (1990). The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells. Proc Natl Acad Sci U S A 87, 8607-8611.
110. Shanmuganathan S, Hausenloy DJ, Duchen MR & Yellon DM (2005). Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 289, H237-H242.
111. Shaul PW (2002). Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64, 749-774.
112. Simmons WW, Closs EI, Cunningham JM, Smith TW & Kelly RA (1996 a). Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and NO production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem 271, 11694-11702.
113. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW & Kelly RA (1996 b). Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem 271, 23928-23937.
114. Steppan J, Ryoo S, Schuleri KH, Gregg C, Hasan RK, White AR, Bugaj LJ, Khan M, Santhanam L, Nyhan D, Shoukas AA, Hare JM & Berkowitz DE (2006). Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S A 103, 4759-4764.
115. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B, Lazzarino G, Paolocci N, Gabrielson KL, Wang Y & Kass DA (2005). Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115, 1221-1231.
116. Tay YM, Lim KS, Sheu FS, Jenner A, Whiteman M, Wong KP & Halliwell B (2004). Do mitochondria make nitric oxide? No? Free Radic Res 38, 591-599.
117. 2+-ATPase. Proc Natl Acad Sci U S A 87, 2466-2470.
118. Thony B, Auerbach G & Blau N (2000). Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347, 1-16.
119. Topal G, Brunet A, Walch L, Boucher JL & David-Dufilho M (2006). Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther 318, 1368-1374.
120. Valdez LB & Boveris A (2007). Mitochondrial nitric oxide synthase, a voltage-dependent enzyme, is responsible for nitric oxide diffusion to cytosol. Front Biosci 12, 1210-1219.
121. Valdez LB, Zaobornyj T, Alvarez S, Bustamante J, Costa LE & Boveris A (2004). Heart mitochondrial nitric oxide synthase. Effects of hypoxia and aging. Mol Aspects Med 25, 49-59.
122. Valdez LB, Zaobornyj T & Boveris A (2006). Mitochondrial metabolic states and membrane potential modulate mtNOS activity. Biochim Biophys Acta 1757, 166-172.
123. van Haeften TW & Konings CH (1989). Arginine pharmacokinetics in humans assessed with an enzymatic assay adapted to a centrifugal analyzer. Clin Chem 35, 1024-1026.
124. Vasquez-Vivar J, Hogg N, Martasek P, Karoui H, Pritchard KA Jr & Kalyanaraman B (1999). Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 274, 26736-26742.
125. Vasquez-Vivar J, Kalyanaraman B & Martasek P (2003). The role of tetrahydrobiopterin in superoxide generation from eNOS: Enzymology and physiological implications. Free Radic Res 37, 121-127.
126. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P & Pritchard KA Jr (1998). Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci U S A 95, 9220-9225.
127. Vukosavljevic N, Jaron D, Barbee KA & Buerk DG (2006). Quantifying the L-arginine paradox in vivo. Microvasc Res 71, 48-54.
128. + current in cat atrial myocytes. J Physiol 567, 143-157.
129. Wang YG, Dedkova EN, Steinberg SF, Blatter LA & Lipsius SL (2002). β 2 -Adrenergic receptor signaling acts via NO release to mediate ACh-induced activation of ATP-sensitive K + current in cat atrial myocytes. J Gen Physiol 119, 69-82.
130. Wang G, Liem DA, Vondriska TM, Honda HM, Korge P, Pantaleon DM, Qiao X, Wang Y, Weiss JN & Ping P (2005 a). Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 288, H1290-H1295.
131. Wever RM, van Dam T, van Rijn HJ, de Groot F & Rabelink TJ (1997). Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 237, 340-344.
132. + pump in cardiac myocytes. Am J Physiol Cell Physiol 294, C572-C578.
133. Wu GY & Brosnan JT (1992). Macrophages can convert citrulline into arginine. Biochem J 281, 45-48.
134. Wu G & Meininger CJ (1993). Regulation of L-arginine synthesis from L-citrulline by L-glutamine in endothelial cells. Am J Physiol Heart Circ Physiol 265, H1965-H1971.
135. Xia Y, Dawson VL, Dawson TM, Snyder SH & Zweier JL (1996). Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 93, 6770-6774.
136. Xu KY, Huso DL, Dawson TM, Bredt DS & Becker LC (1999). Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 96, 657-662.
137. Yokoyama M & Hirata K (2007). Endothelial nitric oxide synthase uncoupling: Is it a physiological mechanism of endothelium-dependent relaxation in cerebral artery? Cardiovasc Res 73, 8-9.
138. Zanella B, Giordano E, Muscari C, Zini M & Guarnieri C (2004). Nitric oxide synthase activity in rat cardiac mitochondria. Basic Res Cardiol 99, 159-164.
139. Zaobornyj T, Gonzales GF & Valdez LB (2007). Mitochondrial contribution to the molecular mechanism of heart acclimatization to chronic hypoxia: Role of nitric oxide. Front Biosci 12, 1247-1259.
140. Zaobornyj T, Valdez LB, La Padula P, Costa LE & Boveris A (2005). Effect of sustained hypobaric hypoxia during maturation and aging on rat myocardium. II. mtNOS activity. J Appl Physiol 98, 2370-2375.
141. Zemojtel T, Kolanczyk M, Kossler N, Stricker S, Lurz R, Mikula I, Duchniewicz M, Schuelke M, Ghafourifar P, Martasek P, Vingron M & Mundlos S (2006). Mammalian mitochondrial nitric oxide synthase: characterization of a novel candidate. FEBS Lett 580, 455-462.
142. Zenebe WJ, Nazarewicz RR, Parihar MS & Ghafourifar P (2007). Hypoxia/ reoxygenation of isolated rat heart mitochondria causes cytochrome c release and oxidative stress: Evidence for involvement of mitochondrial nitric oxide synthase. J Mol Cell Cardiol 43, 411-419.
143. Zou MH, Shi C & Cohen RA (2002). Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109, 817-826.